Status:
COMPLETED
Latest Imaging SPECT System Evaluation Phase 1
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Conditions:
Rheumatic Disease
Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Monocentric study for the evaluation of a whole body CZT scintigraphy system.
Detailed Description
Monocentric evaluation of performances and clinical interest of a whole body scintigraphic acquisition system with CZT digital detectors. Comparison of image quality and resolution of the new system c...
Eligibility Criteria
Inclusion
- Patients referred to our Nuclear Medicine department for bone, cardiac, pulmonary, thyroid, parathyroid, renal or cerebral perfusion scintigraphy or to DaTSCAN.
Exclusion
- Under 18 years old patients.
- Pregnant women or at risk of pregnancy.
- Patients under guardianship
- Painful patient (EVA\>4)
- Patients in whom a standard examination is not feasible (agitation).
Key Trial Info
Start Date :
October 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2021
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04704349
Start Date
October 5 2020
End Date
January 27 2021
Last Update
November 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR d'Orleans
Orléans, France, 45067